GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » RetinalGenix Technologies Inc (OTCPK:RTGN) » Definitions » Equity-to-Asset

RetinalGenix Technologies (RetinalGenix Technologies) Equity-to-Asset : -29.78 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is RetinalGenix Technologies Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. RetinalGenix Technologies's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $-1.52 Mil. RetinalGenix Technologies's Total Assets for the quarter that ended in Mar. 2024 was $0.05 Mil.

The historical rank and industry rank for RetinalGenix Technologies's Equity-to-Asset or its related term are showing as below:

RTGN' s Equity-to-Asset Range Over the Past 10 Years
Min: -887.5   Med: -140.31   Max: -1.31
Current: -29.78

During the past 4 years, the highest Equity to Asset Ratio of RetinalGenix Technologies was -1.31. The lowest was -887.50. And the median was -140.31.

RTGN's Equity-to-Asset is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.64 vs RTGN: -29.78

RetinalGenix Technologies Equity-to-Asset Historical Data

The historical data trend for RetinalGenix Technologies's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RetinalGenix Technologies Equity-to-Asset Chart

RetinalGenix Technologies Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
-1.31 -93.00 - -

RetinalGenix Technologies Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -187.63 -887.50 - - -29.78

Competitive Comparison of RetinalGenix Technologies's Equity-to-Asset

For the Medical Devices subindustry, RetinalGenix Technologies's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RetinalGenix Technologies's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, RetinalGenix Technologies's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where RetinalGenix Technologies's Equity-to-Asset falls into.



RetinalGenix Technologies Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

RetinalGenix Technologies's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=-1.406/0
=

RetinalGenix Technologies's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=-1.519/0.051
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RetinalGenix Technologies  (OTCPK:RTGN) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


RetinalGenix Technologies Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of RetinalGenix Technologies's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


RetinalGenix Technologies (RetinalGenix Technologies) Business Description

Traded in Other Exchanges
N/A
Address
1450 North McDowell Boulevard, Suite 150, Petaluma, CA, USA, 94954
RetinalGenix Technologies Inc is an ophthalmic research and development company focused on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders, Its mission is to prevent vision loss and blindness due to diabetic retinopathy and maculopathy through early detection from the use of two devices: (1) Retinal Imaging Screening Device (RetinalGenixTM), being designed as a portable, high-resolution retinal imaging Diabetic screening system providing a 200-degree field of view without requiring pupil dilation; and (2) RetinalCamTM, being designed as a high-resolution home monitoring retinal imaging device and physician alert system offering real-time communication with physicians available 24/7.

RetinalGenix Technologies (RetinalGenix Technologies) Headlines